Invention Grant
US08377964B2 Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
有权
苯并咪唑 - 甲酰胺化合物作为5-HT 4受体激动剂
- Patent Title: Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists
- Patent Title (中): 苯并咪唑 - 甲酰胺化合物作为5-HT 4受体激动剂
-
Application No.: US12796902Application Date: 2010-06-09
-
Publication No.: US08377964B2Publication Date: 2013-02-19
- Inventor: Robert Murray McKinnell , Roland Gendron , Lan Jiang , Seok-ki Choi , Daniel D. Long , Paul R. Fatheree , Daniel Marquess
- Applicant: Robert Murray McKinnell , Roland Gendron , Lan Jiang , Seok-ki Choi , Daniel D. Long , Paul R. Fatheree , Daniel Marquess
- Applicant Address: US CA South San Francisco
- Assignee: Theravance, Inc.
- Current Assignee: Theravance, Inc.
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah; Roberta P. Saxon
- Main IPC: A61K31/4545
- IPC: A61K31/4545
Abstract:
The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I) wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Public/Granted literature
- US20100249186A1 BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS Public/Granted day:2010-09-30
Information query
IPC分类:
